These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 580416)

  • 1. Plasma insulin disappearance curve after intravenous insulin injection in human hyperthyroidism.
    Wajchenberg BL; Cesar FP; Leme CE; Didio R; Kieffer J
    Clin Endocrinol (Oxf); 1978 Mar; 8(3):233-6. PubMed ID: 580416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-18 induces insulin resistance in the hyperthyroid state.
    Miyauchi S; Matsuura B; Ueda T; Eguchi T; Tamaru M; Yamamoto S; Miyake T; Furukawa S; Abe M; Hiasa Y; Onji M
    Endocr J; 2013; 60(4):449-55. PubMed ID: 23257837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease.
    Ohguni S; Notsu K; Kato Y
    Intern Med; 1995 May; 34(5):339-41. PubMed ID: 7647398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose and insulin metabolism in patients with hyperthyroidism due to Graves' disease.
    Mano T; Kawakubo A; Yamamoto M
    Nagoya J Med Sci; 1994 Mar; 57(1-4):61-8. PubMed ID: 7898563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood glucose and insulin responses to oral glucose in hyperthyroidism].
    Pandolfi C; Pellegrini L; Dedè A
    Minerva Endocrinol; 1996 Jun; 21(2):63-5. PubMed ID: 9026683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
    Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
    Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroid Graves' disease causes insulin antagonism.
    Shen DC; Davidson MB
    J Clin Endocrinol Metab; 1985 May; 60(5):1038-41. PubMed ID: 3884646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin binding to monocytes and in vivo peripheral insulin sensitivity are normal in Graves' disease.
    Cavallo-Perin P; Bruno A; Bozzo C; Boine L; Estivi P; Martina V; Gallone G; Pagano G
    J Endocrinol Invest; 1988 Dec; 11(11):795-800. PubMed ID: 3066814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity in hyperthyroidism: measurement by the glucose clamp technique.
    McCulloch AJ; Home PD; Heine R; Ponchner M; Hanning I; Johnston DG; Clark F; Alberti KG
    Clin Endocrinol (Oxf); 1983 Apr; 18(4):327-33. PubMed ID: 6347438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate metabolism in thyrotoxicosis: studies on insulin secretion before and after remission from the hyperthyroid state.
    Wajchenberg BL; Cesar FP; Leme CE; Souza IT; Pieroni RR; Mattar E
    Horm Metab Res; 1978 Jul; 10(4):294-9. PubMed ID: 355075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin secretion and sensitivity in hyperthyroidism.
    Jap TS; Ho LT; Won JG
    Horm Metab Res; 1989 May; 21(5):261-6. PubMed ID: 2673961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism.
    Osei K; Falko JM; O'Dorisio TM; Adam DR
    Diabetes Care; 1985; 8(5):436-9. PubMed ID: 3902421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylprednisolone increases plasma leptin levels in Graves' hyperthyroidism patients with active Graves' ophthalmopathy.
    Song YM; Lee WJ; Chen MD; Kao CH; Sheu WH
    Horm Metab Res; 2000 Jul; 32(7):277-82. PubMed ID: 10965934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitivity and exogenous insulin clearance in Graves' disease. Measurement by the glucose clamp technique and continuous indirect calorimetry.
    Randin JP; Tappy L; Scazziga B; Jequier E; Felber JP
    Diabetes; 1986 Feb; 35(2):178-81. PubMed ID: 3510924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidism.
    Jenkins RC; Valcavi R; Zini M; Frasoldati A; Heller SR; Camacho-Hubner C; Gibson JM; Westwood M; Ross RJ
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):187-95. PubMed ID: 10671946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthyroidism is associated with higher plasma endothelin-1 concentrations.
    Chu CH; Lee JK; Keng HM; Chuang MJ; Lu CC; Wang MC; Sun CC; Wei MC; Lam HC
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1040-3. PubMed ID: 16741045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypergastrinemia in hyperthyroidism.
    Seino Y; Matsukura S; Miyamoto Y; Goto Y; Taminato T; Imura H
    J Clin Endocrinol Metab; 1976 Oct; 43(4):852-5. PubMed ID: 989772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma insulin response to glibornuride in thyrotoxicosis.
    Federspil G; Zaccaria M; Casara D; Sicolo N; Scandellari C
    Diabete Metab; 1976 Mar; 2(1):27-31. PubMed ID: 136374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment.
    Röjdmark S; Calissendorff J; Danielsson O; Brismar K
    Endocrine; 2005 Jun; 27(1):55-61. PubMed ID: 16077172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients.
    Roti E; Braverman LE; Robuschi G; Salvi M; Gardini E; d'Amato L; Maestri D; Montermini M; Borciani E; Pezzarossa A
    Metabolism; 1986 Apr; 35(4):337-42. PubMed ID: 3515118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.